Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology. Matracell removes a minimum of 97% of donor DNA1, allowing for rapid cellular infiltration and re-vascularization. Dermacell AWM is terminally sterilized, ready to use without refrigeration or re-hydration.
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons-1.png" style="width: 50px; height: 50px; float: left; padding-right: 10px;" />Biohospitable:
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons-2.png" style="width: 50px; height: 50px; float: left; padding-right: 10px;" />Intact Acellular Framework: Retains native growth factors, collagen and elastin.
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons-3.png" style="width: 50px; height: 50px; float: left; padding-right: 10px;" />Room Temperature Storage: Ready to use out of the package (15°C- 30°C).
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons-4.png" style="width: 50px; height: 50px; float: left; padding-right: 10px;" />Proven: Conducted the largest randomized controlled trial (RCT) to date using hADM in chronic wounds.2
Clinical Applications
- Chronic wounds such as diabetic foot ulcers (DFUs), venous stasis ulcers (VSUs), arterial ulcers and pressure ulcers, as well as dehisced surgical wounds and traumatic burns
- Dermacell AWM can be used over exposed tendon, bone, joint capsule, and muscle
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons_wounds-1(2).png" style="width: 200px; height: 200px; padding-right: 10px;" />
Dermacell AWM is a technologically advanced human acellular dermal matrix that is decellularized using Matracell®, a proprietary, patented, and validated processing technology" src="/sites/default/files/images/Dermacell_icons_wounds-2(1).png" style="width: 200px; height: 200px; padding-right: 10px;" />
1. Moore MA, Samsell B, Wallis G, Triplett S, Chen S, Linthurst Jones A, Qin X. Decellularization of human dermis using non-denaturing anionic detergent and endonuclease: a review. Cell Tissue Bank. 2015;16(2):249-259.
2. Cazzell, S., Vayser, D., Pham H., et al. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator. Wound Repair and Regeneration. 2017. 25(3):483-497.